myeloma
Showing 1 - 25 of 4,176
Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)
Not yet recruiting
- Refractory Multiple Myeloma
- +2 more
-
Boston, Massachusetts
- +2 more
Nov 17, 2023
Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)
Not yet recruiting
- Multiple Myeloma
- Teclistamab
- +2 more
-
Miami, FloridaUniversity of Miami
Oct 20, 2023
Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the
Not yet recruiting
- Multiple Myeloma
- +2 more
- 18F-fluciclovine injection
- 18F-FDG PET/CT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 31, 2023
Clinical Pathways for Newly Diagnosed Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Multiple Myeloma Without Mention of Remission
- Multiple Myeloma Pathway
- +2 more
- (no location specified)
Nov 27, 2023
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)
Not yet recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- (no location specified)
Oct 30, 2023
Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)
Not yet recruiting
- Multiple Myeloma
- Immediate yoga intervention
- Delayed yoga intervention
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Sep 27, 2023
Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)
Not yet recruiting
- Smoldering Multiple Myeloma (SMM)
- (no location specified)
Jul 13, 2023
Multiple Myeloma Trial in Zwolle (e-coach multipel myeloma (MM))
Recruiting
- Multiple Myeloma
- e-coach multipel myeloma (MM)
-
Zwolle, Overijssel, NetherlandsIsala Klinieken
Jul 26, 2023
Hypoxia and the Immune Environment in Myeloma Patients (CHIME)
Not yet recruiting
- Myeloma
-
Manchester, Greater Manchester, United KingdomThe Christie NHS Foundation Trust
Aug 16, 2023
Multiple Myeloma Trial in Boston (THRIVE-M)
Not yet recruiting
- Multiple Myeloma
- THRIVE-M
-
Boston, MassachusettsMassachusetts General Hospital
Oct 2, 2023
Multiple Myeloma, Smoldering Multiple Myeloma Trial in Oslo (TG01)
Not yet recruiting
- Multiple Myeloma
- Smoldering Multiple Myeloma
- TG01
-
Oslo, NorwayOslo Myeloma Center
May 2, 2023
Multiple Myeloma Prognostic Indices
Recruiting
- Multiple Myeloma
- Hematologic Diseases
- blood viscosity , albumin / fibrinogen ratio and red cell distribution
-
Assiut, EgyptAssiut University hospital
Oct 17, 2023
Multiple Myeloma Trial (CM313 injection)
Not yet recruiting
- Multiple Myeloma
- CM313 injection
- (no location specified)
Nov 6, 2023
Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)
Not yet recruiting
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Smoldering Multiple Myeloma (SMM)
- (no location specified)
Nov 17, 2023
Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer
Completed
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Myeloma Coach or CLL Coach Mobile App
- Springboard Beyond Cancer informational website
-
Durham, North CarolinaDuke University
Jun 23, 2023
Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)
Recruiting
- Multiple Myeloma
- Total Marrow irradiation,TMI
- Autologous hematopoietic stem cell transplantation
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 24, 2023
Project in First-degree Relatives of Myeloma Patient - The
Recruiting
- Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
- Sample of Blood
-
Shanghai, Shanghai, ChinaZhongshan Hospital,Fudan University
Jul 31, 2023
Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Relapsed and/or Refractory Multiple Myeloma
- BMS-986453
- +2 more
-
Köln, GermanyLocal Institution - 0017
Dec 4, 2023
Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple
Not yet recruiting
- Multiple Myeloma
- +2 more
- Multiple Myeloma M-Protein Analysis
- Multiple Myeloma Knowledge Questionnaires
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 26, 2023
Examination of Trends in Multiple Myeloma Trial Patient
Not yet recruiting
- Multiple Myeloma
- (no location specified)
May 19, 2023
Multiple Myeloma Trial in Montréal (Elranatamab)
Not yet recruiting
- Multiple Myeloma
-
Montréal, Quebec, CanadaMcGill University Health Centre
Sep 21, 2023
Multiple Myeloma in Relapse Trial in Shenzhen (BCMA/GPRC5D double CAR-T)
Recruiting
- Multiple Myeloma in Relapse
- BCMA/GPRC5D double CAR-T
-
Shenzhen, Guangdong, ChinaShenzhen Qianhai Shekou Free Trade Zone Hospital
Sep 28, 2023
Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- Myeloma-Associated Amyloidosis
- Selinexor
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 6, 2023